Niva Bupa Health
Niva Bupa Health Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
Niva Bupa aims to sustain growth 8-10 percentage points faster than the overall market, focusing on retail health (Page 6). The company aims to grow retail health business 8-10% faster than the market through multi-channel diversification and expansion into Tier 2 and 3 cities.
From Niva Bupa Health's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Niva Bupa aims to sustain growth 8-10 percentage points faster than the overall market, focusing on retail health (Page 6).
- Growth drivers include diversified multi-channel distribution, expansion in Tier 2 and Tier 3 towns (Bharat initiative), and continuous advisor network expansion (Page 6).
- New products, such as Reassure 3.0 launched in August last year, have been successful in contributing to growth (Page 6).
- The company leverages AI-led capabilities and GenAI initiatives to enhance advisor and employee productivity, supporting growth (Page 6).
- July 2026 showed strong premium momentum, suggesting positive near-term growth outlook (Page 9).
2 more points from Niva Bupa Health's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Niva Bupa Health said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No explicit mention of current or planned capital expenditure (capex) in the transcript.
- The company has an enabling resolution to raise up to INR 500 crores through debt for growth plans over the next 2 years.
- Existing debt of INR 250 crores has a call option due this year, which is part of the reason for potential debt raise.
- Investment strategy remains conservative but focused on yield, with approximately 4% of AUM committed to Alternative Investment Funds (AIFs), mostly performing credit AIFs, seeking to increase to regulatory limits.
2 more points from Niva Bupa Health's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Niva Bupa Health said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Niva Bupa Health — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹345 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Niva Bupa Health Insurance Company Ltd's management said in earlier quarters
Others in Insurance this season
- New India Assurance Company Ltd (Q1 FY27)
Gross Written Premium (GWP) for Q1 FY26-27: ₹13,720 crore, up 2.90% YoY. Key concall takeaways from New India Assurance Company Ltd's Q1 FY27 earnings call…
- ICICI Lombard (Q1 FY27)
The company reported a 7.5% growth in Gross Direct Premium Income (GDPI) in Q1 FY2027, driven mainly by retail lines, slightly below the industry growth of…
- HDFC Life Insur. (Q1 FY27)
Agency channel growing strongly at around 21%, driven by new agents and branch expansion. Key concall takeaways from HDFC Life Insur.'s Q1 FY27 earnings call…
- Go Digit General Insurance Ltd (Q1 FY27)
Motor business is flat overall; strong growth in 2-wheeler segment (around 21-23%), but decline in commercial vehicles (-27%). Key concall takeaways from Go…
Arthneeti Pro · Annual
Niva Bupa Health and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Niva Bupa Health Q1 FY27 results?
Niva Bupa aims to sustain growth 8-10 percentage points faster than the overall market, focusing on retail health (Page 6). The company aims to grow retail health business 8-10% faster than the market through multi-channel diversification and expansion into Tier 2 and 3 cities.
What is Niva Bupa Health share price analysis?
Niva Bupa Health currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 84.5 with a market cap of ₹14,718 Cr. Investors should review the full earnings analysis for detailed insights.
Is Niva Bupa Health planning capital expenditure?
No explicit mention of current or planned capital expenditure (capex) in the transcript.
Keep Niva Bupa Health on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.